Liletta is under study in a prospective phase 3 clinical trial aimed at extending the approved duration of this levonorgestrel 52-mg IUS.
Suji Uhm, MD, MPH
Advertisement
Articles by Suji Uhm, MD, MPH
Advertisement
Latest Updated Articles
Liletta IUS: not just for long-term contraceptionPublished: May 14th 2020 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Estrogen therapy shows mixed mental health effects in menopause
2
Gene and inflammation factors heighten memory decline after early menopause
3
Cardiovascular disease prevention in women: A discussion with Erin Donnelly Michos, MD
4
Understanding body composition changes during the menopausal transition, with Brooke Aggarwal, EdD
5
